Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Electrochemotherapy treatment saves cat with painful tumour
Pictured: Acai the cat.
The treatment was given by Gerry Poulton at NDSR.

Veterinary professionals at North Downs Specialist Referrals are 'delighted' after a cat with tongue cancer is doing well after receiving electrochemotherapy treatment.

Acai the cat is receiving treatment from oncology specialist Gerry Polton, oncology service director at North Downs Specialist Referrals. 

Gerry, who has described Acai's progress as 'extraordinary', commented on Acai's diagnosis:  “Acai is a lovely big cat who was diagnosed with a squamous cell carcinoma on the underside of his tongue. 

“This is a painful and destructive tumour and, normally, life expectancy for these cases is only about 50 days, with appropriate pain relief.”

With little to no treatment options for Acai's condition, the specialist decided that he was a strong candidate to receive electrochemotherapy treatment, and Acai began treatment in April 2020. 

Electrochemotherapy treatment combines a low dose of a chemotherapy drug and an electrical pulse, applied directly by an electrode. When this electrical pulse is applied, the cells form pores, allowing the drug to enter. 

The practice found that Acai was incredibly receptive to the treatment, with the tumour resolving visibly and the mass being no longer apparent after only three treatments.

After the first course of treatment, which involved six treatments, Acai remained in remission until February 2021, when he then received further electrochemotherapy.

Gerry commented on this process: “We performed two treatments two weeks apart but Acai lost his appetite after the second treatment, so no more were given.

“We expected that the tumour would begin to progress quite rapidly but remarkably he has responded so well and has got his appetite back. 

“It is now 18 months since the lump was first identified and the fact that he is happy and well at this point is extraordinary. 

“We’re delighted and want to share this success story to raise awareness of the treatment so that other cats can benefit from it”

Become a member or log in to add this story to your CPD history

Equine Disease Surveillance report released for Q4 2025

News Story 1
 The latest Equine Disease Surveillance report has been released, with details on equine disease from Q4 of 2025.

The report, produced by Equine Infectious Disease Surveillance, includes advice on rule changes for equine influenza vaccination.

Statistics and maps detail recent outbreaks of equine herpes virus, equine influenza, equine strangles and equine grass sickness. A series of laboratory reports provides data on virology, bacteriology, parasitology and toxicosis.

This issue also features a case study of orthoflavivus-associated neurological disease in a horse in the UK. 

Click here for more...
News Shorts
Applications open for BEVA Back in the Saddle

The British Equine Veterinary Association (BEVA) has opened applications for its 'Back in the Saddle' coaching programme.

The online scheme offers structured group coaching for members wanting to reflect on their career path and regain clarity. Members may be returning to work after leave, uncertain about next steps or reassessing direction.

Attendees will benefit from impartial guidance and practical tools to support their professional development. Members are encouraged to take a 'proactive, future-focused approach' to their careers.

The sessions, taking place on Wednesdays from 7.30pm-9pm, are open to BEVA members with more than five years' experience. The first session takes place on Wednesday, 3 June 2026.

Applications will close on Wednesday, 27 May 2026.